EMB Co Ltd

EMB Co Ltd's capital structure shows a debt-to-equity ratio of 0.7, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.53, suggesting potential short-term liquidity constraints. Despite a positive operating cash flow of KRW 965,693,640, the company's free cash flow is negative at KRW -11,885,206,490, reflecting significant capital outflows [doc:HA-latest]. Profitability metrics are weak, with a return on equity of -0.3942 and a return on assets of -0.189, both significantly below industry norms. The company reported a net loss of KRW -12,815,589,440 and an operating loss of KRW -14,299,004,730, indicating a challenging operating environment [doc:HA-latest]. The company's revenue is distributed across three segments: ESS, Accessories, and Pharmaceuticals. The ESS segment is the primary focus, but the financial data does not provide specific revenue breakdowns by segment. The company's geographic exposure is primarily within South Korea, with no significant international revenue disclosed [doc:HA-latest]. Growth trajectory is mixed. The company's capital expenditure is minimal at KRW -7,364,050, suggesting limited investment in expansion. The outlook for the current fiscal year indicates a continuation of the current performance, with no significant revenue growth expected. The next fiscal year's outlook remains uncertain, with no clear direction provided [doc:HA-latest]. Risk factors include medium liquidity risk and a negative net cash position after subtracting total debt. The company's dilution potential is low, with no significant dilution sources identified. The risk assessment indicates a need for close monitoring of liquidity and debt management [doc:HA-latest]. Recent events include the company's rebranding from Fine EM Tech Co Ltd to EMB Co Ltd, reflecting a strategic shift in focus. No recent filings or transcripts indicate significant operational or financial changes [doc:HA-latest].